Skip to main content
SpringerLink
Log in

Case Report: Severe but Reversible Hepatitis Induced by Troglitazone

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812, 1995

    Google Scholar 

  2. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver × receptor-γ in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327, 1997

    Google Scholar 

  3. Spencer CM, Markham A: Troglitazone. Drugs 54:89-102, 1997

    Google Scholar 

  4. Lee M-K, Miles PD, Khoursheed M, Gao K-M, Moossa AR, Olefsky JM: Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43:1435-1439, 1995

    Google Scholar 

  5. Watkins PB, Whitcomb RW: Hepatic dysfunction associated with troglitazone. N Engl J Med 338:916-917, 1998

    Google Scholar 

  6. Gitlin N, Julie NL, Spurr CL, Lim KN, Juarbe HM: Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Ann Intern Med 129(1):36-38, 1998

    Google Scholar 

  7. Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, Brunt EM: Troglitazone-induced hepatic failure leading to liver transplantation. Ann Intern Med 129(1):38-41, 1998

    Google Scholar 

  8. Vella A, de Groen PC, Dinneen SF: Fatal hepatotoxicity associated with troglitazone. Ann Intern Med 129(12):1080, 1998

    Google Scholar 

  9. Misbin RI: Troglitazone-associated hepatic failure. Ann Intern Med 130(4, pt. 1):330, 1999

    Google Scholar 

  10. Ballare M, Campanini M, Airoldi G, Zaccala G, Bertoncelli MC, Cornaglia G, Porzio M, Monteverde A: Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors. Minerva Gastroenterol Dietol 38:41-44, 1992

    Google Scholar 

  11. Food and Drug Administration: Patient testing and labeling strengthened for Rezulin. Media release, December 1 1997, 2 pp.

Download references

Author information

Authors and Affiliations

  1. Liver Study Unit of the Department of Medicine and Department of Pathology, University of Chicago Medical Center, Chicago, Illinois, 60637

    Thomas Schiano, Kevin Dolehide, John Hart & Alfred L. Baker

Authors
  1. Thomas Schiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin Dolehide
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Hart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alfred L. Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiano, T., Dolehide, K., Hart, J. et al. Case Report: Severe but Reversible Hepatitis Induced by Troglitazone. Dig Dis Sci 45, 1039–1042 (2000). https://doi.org/10.1023/A:1005510132625

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005510132625

Search

Navigation